(Total Views: 398)
Posted On: 08/14/2019 8:58:28 AM
Post# of 156432
This is an old image from ihub (ignore the added graphics).
But it was 90% for 525mg for first 100 patients, then when they enrolled all the new patients in February, it of course went to 95%, since those new patients were early post 10 weeks and had not failed yet. I expected this to drift back down to 90% (for both 525mg and 700mg). The fact is has stayed at 94% for 525mg is amazing to me, the new group starting after Feb must be at 98-99% post 10 weeks. This group I believe had the overlap, but something is different with the new group 90% old vs 98% or so if I am right, is huge.
But it was 90% for 525mg for first 100 patients, then when they enrolled all the new patients in February, it of course went to 95%, since those new patients were early post 10 weeks and had not failed yet. I expected this to drift back down to 90% (for both 525mg and 700mg). The fact is has stayed at 94% for 525mg is amazing to me, the new group starting after Feb must be at 98-99% post 10 weeks. This group I believe had the overlap, but something is different with the new group 90% old vs 98% or so if I am right, is huge.
(1)
(0)
